Skip navigation
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Oncology meetings & conferences

33 meetings & conferences listed in Oncology 

6th International Advanced Research Workshop on In Silico Oncology and Cancer Investigation – The CHIC Project Workshop

6th International Advanced Research Workshop on In Silico Oncology and Cancer Investigation – The CHIC Project Workshop

3-4 November 2014 Athens, Greece

In silico medicine, an emergent scientific and technological domain based on clinically driven and oriented multiscale biomodeling, appears to be the latest trend regarding the translation of mathematical and computational biological science to clinical practice through massive exploitation of information technology. The term multiscale refers to several scales or levels of the manifestation of life such as the molecular, the cellular, the tissue, the organ, and the body system scales addressed concurrently.

The overarching idea is to view disease as a hypercomplex and multiscale natural phenomenon amenable to modeling and simulation. In silico (i.e., on the computer) experimentation for each individual patient using their own multiscale biomedical data is expected to significantly improve the effectiveness of treatment in the future, since reliable computer predictions could suggest the optimal treatment scheme(s) and schedules(s) for each separate case.

Clinically driven complex multiscale cancer models can produce realistic spatio-temporal simulations of concrete clinical interventions such as radio-chemotherapy applied to individual patients.

Clinical data processing procedures and computer technologies play an important role in this context. Following clinical adaptation and validation within the framework of clinico-genomic trials, models are expected to enhance individualized treatment optimization.  The latter constitutes the long term goal of the emergent scientific, technological and medical discipline of in silico oncology.

Treatment optimization is to be achieved through experimentation in silico. Moreover, provision of insight into tumour dynamics and optimization of clinical trial design and interpretation constitute short- and mid-term goals of this new domain.

The workshop to be held in Athens, Greece  is meant to be an excellent opportunity for both shaping and advancing the new discipline.

CHIC stands for Computational Horizons in Cancer (CHIC): Developing Meta- and Hyper-Multiscale Models and Respositories for In Silico Oncology

Biologist, Computer Scientist, Oncologist, Physician Researcher
World Congress on Controversies in Breast Cancer

World Congress on Controversies in Breast Cancer

October 22-25, 2015 Melbourne, Australia

Congresses are numerous, but few address the key issues facing clinicians in their daily practice. New information is often presented, but rarely in a form that is ready for use and the gap between theory and practice is not always addressed. The CoBRA congress will be different. It will deal with controversial issues in aspects of breast cancer care, with presentations, debates and discussions. The congress will provide a forum for key opinion leaders to effectively debate unresolved clinical and therapeutic dilemmas.

Oncologist, Physician, Physician Researcher
4th International Conference on Computational & Mathematical Biomedical Engineering

4th International Conference on Computational & Mathematical Biomedical Engineering

29 June - 1 July 2015

Ecole Normale Superieure de Cahan (ENS Cachan) 61 Avenue du President Wilson 94230 Cachan, France

Computational and Mathematical Biomedical Engineering is a rapidly expanding research area with the promise of considerable implications on human health and wellbeing. Computational and mathematical modelling now plays a significant role in improving our knowledge of the biological processes in the human body and the pathophysiology of diseases. In addition, it supports the development of appropriate diagnostic tools, new instrumentation and medical devices to enable better clinical outcomes.

The International Conference on Computational & Mathematical Biomedical Engineering aims at bringing together fellow researchers and academics, specialists of several disciplines, practitioners and graduate students with a common interest, to discuss the current state of the art of Computational Biomedical Engineering research.


• Cardiovascular problems

• Respiratory systems

• Biofluid Mechanics

• Soft tissue, constitutive modelling

• Experimental validation

• Numerical methods

• Multiscale modelling

• Analytical approaches

• High performance computing

• Biological heat and mass transfer

• Biology and its links to diseases

• Biomechanics and Oncology

• Clinical relevance

• Imaging and image processing

• Uncertainty quantification

• Biomedical devices

Biologist, Biomedical Engineer, Computer Scientist, Physician Researcher, Technologist
Association of Oncology Social Work 31st Annual Conference
United States

Association of Oncology Social Work 31st Annual Conference

“Leading With Skill and Passion: Oncology Social Workers at the Forefront of Cancer Care”

May 20-22, 2015 Seattle, Washington

The AOSW Annual Conference is a unique opportunity for oncology social workers, their colleagues and companies that support patients and healthcare providers to gather information, share knowledge, support and guide each other.

Each year, AOSW Annual Conference Committee members organize the annual conference around presentations and educational sessions that reflect the most current issues facing adult oncology social workers, while also embracing and incorporating lessons previously shared. In this way AOSW honors its past as it prepares to meet future challenges and opportunities that are not only welcomed but actively sought.

The AOSW 31st Annual Conference in 2015 will be held in Seattle, Washington, USA. Known for its spirit of optimism, Seattle is an ideal backdrop for the AOSW conference. Like AOSW, Seattle places a priority on continuing to expand and grow its diverse communities.

Social Worker
2015 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer
United States

2015 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer

March 28-31, 2015 Chicago, Illinois

Since 1969, women’s health care professionals have convened at the Society of Gynecologic Oncology (SGO)’s Annual Meeting on Women’s Cancer to discuss the latest science in the field, receive educational programming, and to network. Now in its 46th year, the SGO Annual Meeting continues to be the premier educational and scientific event for those who treat and care for women with gynecologic cancer.

Members of the entire gynecologic cancer care team who provide treatment and care in the areas of chemotherapy, radiation therapy, surgery, and palliative care attend the SGO Annual Meeting. Gynecologic oncologists make up a large population of the attendees, along with medical oncologists, pathologists, radiation oncologists, hematologists, surgical oncologists, obstetrician/gynecologists, nurses, physician assistants, fellows in training, residents, and social workers.

The SGO Annual Meeting also brings together exhibitors from a variety of medical device and service companies. An array of state-of-the-art products and services geared towards members of the gynecologic cancer care team are on display in the exhibition area.

Hematologist, Medical Resident, Nurse, Oncologist, Pathologist, Physician Researcher, Postdoctoral Fellow, Radiation Oncologist, Social Worker
EMBL Conference: Cancer Genomics

EMBL Conference: Cancer Genomics

Sunday 1 November - Wednesday 4 November 2015 European Molecular Biology Laboratory Heidelberg, Germany

• Topics

◦ Cancer Genetics

◦ Functional Genomics & Epigenomics of Cancer

◦ Systems Biology & Integrated Analyses of Cancer

◦ Cancer Model Systems & Systems Pharmacology

◦ Translation & Clinical Impact of Cancer Genomics

This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models, and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium ( projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2013 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions, and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.

Biologist, Geneticist , Molecular Biologist, Oncologist, Pharmacologist, Physician Researcher
2015 Controlling Cancer Summit
United Kingdom

2015 Controlling Cancer Summit

Tuesday, 12 May 2015 09:00 - Thursday, 14 May 2015 17:00 London, United Kingdom

With plenty of opportunity  for networking and debate, this informal international  meeting will bring you up to date with current research and thinking regarding cancer screening, prevention and treatment.  Presenters will include Clinicians, Academics and members of the Pharmaceutical industry.

Who Should Attend

The conference is open to academics, clinicians and industrial partners creating a stimulating environment in which to promote lively discussion, productive collaboration and innovation.

Academic, Oncologist, Pharmacologist, Physician, Physician Researcher
MicroRNAs and Noncoding RNAs in Cancer
United States

MicroRNAs and Noncoding RNAs in Cancer

June 7—12, 2015 Keystone, Colorado

MicroRNAs and other noncoding RNAs have recently emerged as key regulators of gene expression during development and are frequently mis-expressed in human disease states, in particular cancer. MicroRNAs act to promote or repress cell proliferation, migration and apoptosis during development, all processes that go awry in cancer. Thus, microRNAs have the ability to behave like oncogenes or tumor suppressors. Their small size and molecular properties make microRNAs amenable as targets and therapeutics in cancer treatment. MicroRNAs thus present a paradigm shift in thinking about gene regulation during development and disease and provide the oncologist with a potentially powerful new battery of agents to diagnose and treat cancer. However, while hundreds of human microRNAs and noncoding RNAs are known, relatively little is known about their roles and targets, and there is still a limited literature on using these molecules in the clinic. The specific aims of this meeting serve to address these deficiencies and are as follows: 1) Focus on the exciting biology of microRNAs and noncoding RNAs in controlling developmental and cancer processes like cell proliferation, differentiation, cell cycle, apoptosis and metastasis. This meeting will highlight the best current research into the role that miRNAs play in these fundamental processes and provide the basic understanding that will drive the invention of powerful clinical tools; 2) Focus on the latest efforts to harness the power of these RNAs as agents in the fight against cancer. Discussions will range from use of miRNAs as diagnostic and prognostic markers in cancer, to SNPs providing risk factors for cancer, to the delivery and effectiveness of small RNA therapeutics in clinically relevant settings; 3) Attract the best researchers working in small RNAs and cancer to one place for critical discussions that will advance the field and accelerate the benchside to bedside use of this technology; and 4) Provide a stimulating environment where students, postdocs and junior investigators can present and discuss their research with the best minds in the field.

Cell Biologist, Graduate Student, Junior Investigator, Junior Researcher, Junior Scientist, Molecular Biologist, Oncologist, Physician Researcher, Postdoctoral Fellow
Viruses and Human Cancer
United States

Viruses and Human Cancer

March 29—April 3, 2015 Big Sky, Montana

In 1970, an authoritative book entitled “Viruses and Cancer” was published by Sir Christopher Andrews, one of the discoverers of influenza virus. On page 135 he wrote “Despite these findings, there is no doubt that as regards the generality of cancers in man, and indeed in other mammals, there is no direct evidence that viruses are concerned”. It is now estimated that about 20% of human cancers are caused by infectious agents, among them at least 7 viruses. The increasing appreciation of the role of viruses in cancer pathogenesis has not only already led to the development of two successful vaccines (against HBV and HPV) that prevent cancer, it has also directly contributed to many fundamental discoveries in cancer biology. In the last decade the understanding of virus-induced cancers has been accelerated by the extraordinary developments in genomics, epigenetics and RNA biology. To review this rapidly burgeoning field, this multidisciplinary symposium brings together experts in virology, oncology, immunology, genomics and genetics. The objective of the symposium is to explore how advances in cancer biology can inform the understanding of virus-induced cancers, and how viruses continue to reveal fundamental principles in cancer. Particular emphasis will be laid on the interaction between virus and host in persistent infections by oncogenic viruses. The meeting will cover examples of cancers where a viral cause is still under debate and the rapid development of technology for the detection of unknown viruses.

Geneticist , Immunologist, Molecular Biologist, Oncologist, Physician Researcher, Virologist